Abstract
BackgroundWe examined the risk for Group B streptococcus (GBS)-related diseases in newborns born to mothers who participated in a universal GBS screening program and to determine whether differences are observed in factors affecting the morbidity for neonatal early-onset GBS-related diseases.MethodsThis is a retrospective study and the study subjects were women who had undergone GBS screening and who gave birth naturally and their newborns between April 15, 2012 and December 31, 2013. Data from the GBS screening system database and the National Health Insurance database were collected to calculate the GBS prevalence in pregnant women and morbidity of newborns with early-onset GBS-related diseases.ResultsThe GBS prevalence in pregnant women who gave birth naturally was 19.58%. The rate of early-onset infection caused by GBS in newborns decreased from the original 0.1% to 0.02%, a decrease of as high as 80%. After the implementation of the universal GBS screening program, only three factors, including positive GBS screening result (OR = 2.84), CCI (OR = 2.45), and preterm birth (OR = 4.81) affected the morbidity for neonatal early-onset GBS-related diseases, whereas other factors had no significant impact.ConclusionThe implementation of the universal GBS screening program decreased the infection rate of neonatal early-onset GBS diseases. The effects of socioeconomic factors and high-risk pregnancy on early-onset GBS infections were weakened.
Highlights
We examined the risk for Group B streptococcus (GBS)-related diseases in newborns born to mothers who participated in a universal GBS screening program and to determine whether differences are observed in factors affecting the morbidity for neonatal early-onset GBS-related diseases
With regard to factors related to the morbidity of newborns with GBS-related diseases, past studies suggested that these factors included vaginal birth, maternal vaginal and rectal GBS infection, preterm babies delivered before 37 weeks of gestation, rupture of the amniotic sac
We focused on several issues, including the following under this health policy mode: whether differences in the morbidity rate for GBSrelated diseases in pregnant women and newborns are observed, whether different factors affect the morbidity for neonatal GBS-related diseases, and which influencing factors are weakened or strengthened after the implementation of this universal screening program
Summary
We examined the risk for Group B streptococcus (GBS)-related diseases in newborns born to mothers who participated in a universal GBS screening program and to determine whether differences are observed in factors affecting the morbidity for neonatal early-onset GBS-related diseases. Hospital types and levels, maternal disease history, newborn birth weight, number of fetuses, and comorbidities/complications affect the neonatal morbidity for GBS-related diseases [13]. The implementation of all comprehensive screening policies can help understand the status of pregnant women with GBS infection. This will facilitate early detection and antibiotic treatment that will decrease the probability of neonatal infection, thereby reducing damage, regrets, and medical expenditure [1]. The incidence of neonatal GBS-related diseases can be decreased through the administration of antibiotic prophylaxis during childbirth in pregnant women who are carriers. A screen-based method can identify GBS-positive women who must be given antibiotic prophylaxis to decrease the probability of newborns developing early-onset GBS-related diseases. The establishment of a notification system for long-term data collection can be an important reference for the government in the establishment of GBS prevention policies [19]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
